Cumberland Pharmaceuticals (CPIX) Share-based Compensation (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Share-based Compensation across 17 years of filings, most recently posting $106842.0 for Q1 2026.

• Share-based Compensation for Q1 2026 came in at $106842.0, up 43.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $440950.0 (up 48.29% YoY), and the FY2025 annual result was $408320.0, up 35.25% from the prior year.
• Share-based Compensation came in at $106842.0 for Q1 2026 at Cumberland Pharmaceuticals, down from $172160.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $188450.0 in Q3 2022 to a low of -$27753.0 in Q2 2022.
• The 5-year median for Share-based Compensation is $83112.0 (2023), against an average of $95858.8.
• Across the five-year window, Share-based Compensation sank 114.46% in 2022 and jumped 452.68% in 2023, its largest moves.
• Cumberland Pharmaceuticals' Share-based Compensation stood at $126905.0 in 2022, then fell by 26.01% to $93894.0 in 2023, then retreated by 20.32% to $74812.0 in 2024, then surged by 130.12% to $172160.0 in 2025, then plunged by 37.94% to $106842.0 in 2026.
• The last three Share-based Compensation figures came in at $106842.0 (Q1 2026), $172160.0 (Q4 2025), and $81262.0 (Q3 2025), per Business Quant data.